Download PDF
Kardiologie up2date 2011; 7(3): 181-198
DOI: 10.1055/s-0030-1256868
Diagnostische Verfahren und Bildgebung

© Georg Thieme Verlag KG Stuttgart · New York

Nicht invasive Diagnostik bei Kardiomyopathien

Ralf  Waßmuth, Christian  Prinz, Lothar  Faber
Further Information

Publication History

Publication Date:
25 October 2011 (online)

Also available at
    Permissions and Reprints All articles of this category

Abstract

Noninvasive cardiac imaging is important in the clinical management of cardiomyopathies. According to the European Society of Cardiology classification of cardiomyopathies we systematically review points to consider and potential pitfalls in the assessment of cardiomyopathy patients by echocardiography and cardiovascular magnetic resonance imaging (CMR). We compare strengths and disadvantages of echo and CMR in various diagnostic settings. In most circumstances complementary use of echocardiography and CMR will be the optimal basis for diagnosis and treatment decisions in dilated, hypertrophic, arrhythmogenic, restrictive, and other cardiomyopathies.

Literatur

  • 1 Richardson P, McKenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.  Circulation. 1996;  93 841-842
    Google Scholar
  • 2 Maron B J, Towbin J A, Thiene G et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.  Circulation. 2006;  113 1807-1816
    Google Scholar
  • 3 Elliott P, Andersson B, Arbustini E et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.  Eur Heart J. 2008;  29 270-276
    Google Scholar
  • 4 Devereux R B, Roman M J, Paranicas M et al. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study.  Am Heart J. 2001;  141 439-446
    Google Scholar
  • 5 Buck T, Breithardt O A, Faber L et al. Leitlinie zur Indikation, Durchführung und zum klinischen Stellenwert der Echokardiographie.  Clin Res Cardiol. 2009;  (Suppl. 4) 3-51
    Google Scholar
  • 6 Cleland J G, Coletta A P, Yassin A et al. Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT.  Eur J Heart Fail. 2009;  11 1214-1219
    Google Scholar
  • 7 Hansen A, Haass M, Zugck C et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure.  J Am Coll Cardiol. 2001;  37 1049-1055
    Google Scholar
  • 8 Paulus W J, Tschope C, Sanderson J E et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.  Eur Heart J. 2007;  28 2539-2550
    Google Scholar
  • 9 Bleeker G B, Steendijk P, Holman E R et al. Assessing right ventricular function: the role of echocardiography and complementary technologies.  Heart. 2006;  92 (Suppl. 1) i19-i26
    Google Scholar
  • 10 Rahimtoola S H. Concept and evaluation of hibernating myocardium.  Annu Rev Med. 1999;  50 75-86
    Google Scholar
  • 11 McCrohon J A, Moon J C, Prasad S K et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.  Circulation. 2003;  108 54-59
    Google Scholar
  • 12 Assomull R G, Prasad S K, Lyne J et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.  J Am Coll Cardiol. 2006;  48 1977-1985
    Google Scholar
  • 13 Lehrke S, Lossnitzer D, Schob M et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy.  Heart. 2011;  97 727-732
    Google Scholar
  • 14 Chung E S, Leon A R, Tavazzi L et al. Results of the Predictors of Response to CRT (PROSPECT) trial.  Circulation. 2008;  117 2608-2616
    Google Scholar
  • 15 Faber L, Lamp B, Hering D et al. [Analysis of inter- and intraventricular asynchrony by tissue Doppler echocardiography].  Z Kardiol. 2003;  92 994-1002
    Google Scholar
  • 16 Breithardt O A, Stellbrink C, Herbots L et al. Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block.  J Am Coll Cardiol. 2003;  42 486-494
    Google Scholar
  • 17 White J A, Yee R, Yuan X et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony.  J Am Coll Cardiol. 2006;  48 1953-1960
    Google Scholar
  • 18 Bleeker G B, Kaandorp T A, Lamb H J et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy.  Circulation. 2006;  113 969-976
    Google Scholar
  • 19 Marsan N A, Westenberg J J, Ypenburg C et al. Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue.  Eur Heart J. 2009;  30 2360-2367
    Google Scholar
  • 20 Leyva F, Foley P W, Chalil S et al. Cardiac resynchronisation therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance.  J Cardiovasc Magn Reson. 2011;  13 29
    Google Scholar
  • 21 Delfino J G, Fornwalt B K, Eisner R L et al. Cross-correlation delay to quantify myocardial dyssynchrony from phase contrast magnetic resonance (PCMR) velocity data.  J Magn Reson Imaging. 2008;  28 1086-1091
    Google Scholar
  • 22 Kuhl U, Pauschinger M, Schwimmbeck P L et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.  Circulation. 2003;  107 2793-2798
    Google Scholar
  • 23 Staudt A, Bohm M, Knebel F et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.  Circulation. 2002;  106 2448-2453
    Google Scholar
  • 24 ten Berg J, Steggerda R C, Siebelink H M. Myocardial disease: The patient with hypertrophic cardiomyopathy.  Heart. 2010;  96 1764-1772
    Google Scholar
  • 25 Watkins H, Ashrafian H, Redwood C. Inherited cardiomyopathies.  N Engl J Med. 2011;  364 1643-1656
    Google Scholar
  • 26 Maron B J, Gardin J M, Flack J M et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.  Circulation. 1995;  92 785-789
    Google Scholar
  • 27 Maron B J, McKenna W J, Danielson G K et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.  Eur Heart J. 2003;  24 1965-1991
    Google Scholar
  • 28 Elliott P M, Poloniecki J, Dickie S et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.  J Am Coll Cardiol. 2000;  36 2212-2218
    Google Scholar
  • 29 Maron B J, Spirito P, Shen W K et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.  JAMA. 2007;  298 405-412
    Google Scholar
  • 30 Pelliccia A, Di Paolo F M, Maron B J. The athlete"s heart: remodeling, electrocardiogram and preparticipation screening.  Cardiol Rev. 2002;  10 85-90
    Google Scholar
  • 31 Pelliccia A, Fagard R, Bjornstad H H et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.  Eur Heart J. 2005;  26 1422-1445
    Google Scholar
  • 32 Sipola P, Magga J, Husso M et al. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.  Eur Radiol. 2011;  21 1383-1389
    Google Scholar
  • 33 Adabag A S, Maron B J, Appelbaum E et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.  J Am Coll Cardiol. 2008;  51 1369-1374
    Google Scholar
  • 34 Pieroni M, Chimenti C, Ricci R et al. Early detection of Fabry cardiomyopathy by tissue Doppler imaging.  Circulation. 2003;  107 1978-1984
    Google Scholar
  • 35 Weidemann F, Breunig F, Beer M et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study.  Circulation. 2003;  108 1299-1301
    Google Scholar
  • 36 Nagueh S F, McFalls J, Meyer D et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.  Circulation. 2003;  108 395-398
    Google Scholar
  • 37 Reckefuss N, Butz T, Horstkotte D, Faber L. Evaluation of longitudinal and radial left ventricular function by two-dimensional speckle-tracking echocardiography in a large cohort of normal probands.  Int J Cardiovasc Imaging. 2011;  27 515-526
    Google Scholar
  • 38 Serri K, Reant P, Lafitte M et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy.  J Am Coll Cardiol. 2006;  47 1175-1181
    Google Scholar
  • 39 Nagueh S F, Bierig S M, Budoff M J et al. American society of echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy endorsed by the american society of nuclear cardiology, society for cardiovascular magnetic resonance, and society of cardiovascular computed tomography.  J Am Soc Echocardiogr. 2011;  24 473-498
    Google Scholar
  • 40 Moon J C, Fisher N G, McKenna W J, Pennell D J. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.  Heart. 2004;  90 645-649
    Google Scholar
  • 41 Rickers C, Wilke N M, Jerosch-Herold M et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.  Circulation. 2005;  112 855-861
    Google Scholar
  • 42 Maron M S, Finley J J, Bos J M et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.  Circulation. 2008;  118 1541-1549
    Google Scholar
  • 43 Desai M Y, Ommen S R, McKenna W J et al. Imaging phenotype versus genotype in hypertrophic cardiomyopathy.  Circ Cardiovasc Imaging. 2011;  4 156-168
    Google Scholar
  • 44 Minami Y, Kajimoto K, Terajima Y et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy.  J Am Coll Cardiol. 2011;  57 2346-2355
    Google Scholar
  • 45 Maceira A M, Cosin-Sales J, Roughton M et al. Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance.  J Cardiovasc Magn Reson. 2010;  12 65
    Google Scholar
  • 46 Rubinshtein R, Glockner J F, Ommen S R et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.  Circ Heart Fail. 2010;  3 51-58
    Google Scholar
  • 47 Bruder O, Wagner A, Jensen C J et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.  J Am Coll Cardiol. 2010;  56 875-887
    Google Scholar
  • 48 O'Hanlon R, Grasso A, Roughton M et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.  J Am Coll Cardiol. 2010;  56 867-874
    Google Scholar
  • 49 Bos J M, Theis J L, Tajik A J et al. Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy.  Am Heart J. 2008;  155 1128-1134
    Google Scholar
  • 50 Mahrholdt H, Wagner A, Judd R M et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.  Eur Heart J. 2005;  26 1461-1474
    Google Scholar
  • 51 Rudolph A, Abdel-Aty H, Bohl S et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.  J Am Coll Cardiol. 2009;  53 284-291
    Google Scholar
  • 52 Petersen S E, Jerosch-Herold M, Hudsmith L E et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.  Circulation. 2007;  115 2418-2425
    Google Scholar
  • 53 Schulz-Menger J, Strohm O, Waigand J et al. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization.  Circulation. 2000;  101 1764-1766
    Google Scholar
  • 54 Faber L, Seggewiss H, Welge D et al. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.  Eur J Echocardiogr. 2004;  5 347-355
    Google Scholar
  • 55 Prinz C, Farr M, Hering D et al. The diagnosis and treatment of hypertrophic cardiomyopathy.  Dtsch Arztebl Int. 2011;  108 209-215
    Google Scholar
  • 56 Butz T, Horstkotte D, Langer C et al. Significant obstruction of the right and left ventricular outflow tract in a patient with biventricular hypertrophic cardiomyopathy.  Eur J Echocardiogr. 2008;  9 344-345
    Google Scholar
  • 57 Kwon D H, Smedira N G, Thamilarasan M et al. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation.  J Thorac Cardiovasc Surg. 2010;  140 317-324
    Google Scholar
  • 58 Gemayel C, Pelliccia A, Thompson P D. Arrhythmogenic right ventricular cardiomyopathy.  J Am Coll Cardiol. 2001;  38 1773-1781
    Google Scholar
  • 59 McKenna W J, Thiene G, Nava A et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.  Br Heart J. 1994;  71 215-218
    Google Scholar
  • 60 Corrado D, Fontaine G, Marcus F I et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. European Society of Cardiology and the Scientific Council on Cardiomyopathies of the World Heart Federation.  J Cardiovasc Electrophysiol. 2000;  11 827-832
    Google Scholar
  • 61 Yoerger D M, Marcus F, Sherrill D et al. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia.  J Am Coll Cardiol. 2005;  45 860-865
    Google Scholar
  • 62 Marcus F I, McKenna W J, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.  Eur Heart J. 2010;  31 806-814
    Google Scholar
  • 63 Sen-Chowdhry S, Syrris P, Prasad S K et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.  J Am Coll Cardiol. 2008;  52 2175-2187
    Google Scholar
  • 64 Pinamonti B, Dragos A M, Pyxaras S A et al. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry.  Eur Heart J. 2011;  32 1105-1113
    Google Scholar
  • 65 Heidbuchel H, Hoogsteen J, Fagard R et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification.  Eur Heart J. 2003;  24 1473-1480
    Google Scholar
  • 66 Vermes E, Strohm O, Otmani A et al. Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria.  JACC Cardiovasc Imaging. 2011;  4 282-287
    Google Scholar
  • 67 Bluemke D A, Krupinski E A, Ovitt T et al. MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability.  Cardiology. 2003;  99 153-162
    Google Scholar
  • 68 Tandri H, Saranathan M, Rodriguez E R et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.  J Am Coll Cardiol. 2005;  45 98-103
    Google Scholar
  • 69 Hunold P, Wieneke H, Bruder O et al. Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy?.  J Cardiovasc Magn Reson. 2005;  7 649-655
    Google Scholar
  • 70 Chatterjee K, Alpert J. Constrictive pericarditis and restrictive cardiomyopathy: similarities and differences.  Heart Fail Monit. 2003;  3 118-126
    Google Scholar
  • 71 Mogensen J, Kubo T, Duque M et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.  J Clin Invest. 2003;  111 209-216
    Google Scholar
  • 72 Piper C, Butz T, Farr M et al. How to diagnose cardiac amyloidosis early: impact of ECG, tissue Doppler echocardiography, and myocardial biopsy.  Amyloid. 2010;  17 1-9
    Google Scholar
  • 73 Ha J W, Oh J K, Ommen S R et al. Diagnostic value of mitral annular velocity for constrictive pericarditis in the absence of respiratory variation in mitral inflow velocity.  J Am Soc Echocardiogr. 2002;  15 1468-1471
    Google Scholar
  • 74 Maisch B, Seferovic P M, Ristic A D et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology.  Eur Heart J. 2004;  25 587-610
    Google Scholar
  • 75 Butz T, Piper C, Langer C et al. Diagnostic superiority of a combined assessment of the systolic and early diastolic mitral annular velocities by tissue Doppler imaging for the differentiation of restrictive cardiomyopathy from constrictive pericarditis.  Clin Res Cardiol. 2010;  99 207-215
    Google Scholar
  • 76 Comenzo R L, Gertz M A. Autologous stem cell transplantation for primary systemic amyloidosis.  Blood. 2002;  99 4276-4282
    Google Scholar
  • 77 Jategaonkar S, Butz T, Faber L. [Surgical treatment of the hypereosinophilic syndrome with cardiac involvement (Loffler's endocarditis)].  Dtsch Med Wochenschr. 2008;  133 570-572
    Google Scholar
  • 78 Khouri S J, Maly G T, Suh D D, Walsh T E. A practical approach to the echocardiographic evaluation of diastolic function.  J Am Soc Echocardiogr. 2004;  17 290-297
    Google Scholar
  • 79 Oh J K, Hatle L, Tajik A J, Little W C. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography.  J Am Coll Cardiol. 2006;  47 500-506
    Google Scholar
  • 80 Lapu-Bula R, Robert A, De Kock M et al. Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling.  Am J Cardiol. 1998;  82 779-785
    Google Scholar
  • 81 Maceira A M, Joshi J, Prasad S K et al. Cardiovascular magnetic resonance in cardiac amyloidosis.  Circulation. 2005;  111 186-193
    Google Scholar
  • 82 Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases.  J Cardiovasc Magn Reson. 2009;  11 14
    Google Scholar
  • 83 Taylor A M, Dymarkowski S, Verbeken E K, Bogaert J. Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results.  Eur Radiol. 2006;  16 569-574
    Google Scholar
  • 84 Dawson D, Rubens M, Mohiaddin R. Contemporary imaging of the pericardium.  JACC Cardiovasc Imaging. 2011;  4 680-684
    Google Scholar
  • 85 Pignatelli R H, McMahon C J, Dreyer W J et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy.  Circulation. 2003;  108 2672-2678
    Google Scholar
  • 86 Engberding R, Stollberger C, Ong P et al. Isolated non-compaction cardiomyopathy.  Dtsch Arztebl Int. 2010;  107 206-213
    Google Scholar
  • 87 Oechslin E, Jenni R. Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?.  Eur Heart J. 2011;  32 1446-1456
    Google Scholar
  • 88 Dawson D K, Maceira A M, Raj V J et al. Regional thicknesses and thickening of compacted and trabeculated myocardial layers of the normal left ventricle studied by cardiovascular magnetic resonance.  Circ Cardiovasc Imaging. 2011;  4 139-146
    Google Scholar
  • 89 Petersen S E, Selvanayagam J B, Wiesmann F et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging.  J Am Coll Cardiol. 2005;  46 101-105
    Google Scholar
  • 90 Jacquier A, Thuny F, Jop B et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction.  Eur Heart J. 2010;  31 1098-1104
    Google Scholar
  • 91 Alsaileek A A, Syed I, Seward J B, Julsrud P. Myocardial fibrosis of left ventricle: magnetic resonance imaging in noncompaction.  J Magn Reson Imaging. 2008;  27 621-624
    Google Scholar
  • 92 Matsumoto N, Sato Y, Kasama S et al. Myocardial necrosis in both left and right ventricles detected by delayed-enhanced magnetic resonance imaging in a patient with isolated noncompaction of the ventricular myocardium.  Int J Cardiol. 2009;  133 e94-96
    Google Scholar
  • 93 Probst S, Oechslin E, Schuler P et al. Sarcomere Gene Mutations in Isolated Left Ventricular Noncompaction Cardiomyopathy Do Not Predict Clinical Phenotype.  Circ Cardiovasc Genet. 2011;  4 367-371
    Google Scholar
  • 94 Schneider B, Athanasiadis A, Schwab J et al. [Clinical spectrum of tako-tsubo cardiomyopathy in Germany: results of the tako-tsubo registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)].  Dtsch Med Wochenschr. 2010;  135 1908-1913
    Google Scholar
  • 95 Eitel I, Behrendt F, Schindler K et al. Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging.  Eur Heart J. 2008;  29 2651-2659
    Google Scholar
  • 96 Eitel I, Lucke C, Grothoff M et al. Inflammation in takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging.  Eur Radiol. 2010;  20 422-431
    Google Scholar

Prof. Dr. L. Faber

Kardiologische Klinik
Herz- und Diabeteszentrum Nordrhein-Westfalen
Ruhr-Universität Bochum

Georgstraße 11

32545 Bad Oeynhausen

Phone: 05731 97–1258

Fax: 05731 97–2194

Email: akleemeyer@hdz-nrw.de